Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 265
7
Diseases
20
Unique genes
0.196
Avg. similarity score
Osteopetrosis
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Osteopetrosis
Osteosclerosis
autosomal dominant osteopetrosis 2
autosomal recessive osteopetrosis 4
hypopigmentation, organomegaly, and delayed myelination and development
autosomal recessive osteopetrosis 5
autosomal recessive osteopetrosis 8
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Osteopetrosis | 6 | 6 | 17 |
| Osteosclerosis | 4 | 4 | 8 |
| autosomal dominant osteopetrosis 2 | 4 | 4 | 1 |
| autosomal recessive osteopetrosis 4 | 4 | 4 | 1 |
| hypopigmentation, organomegaly, and delayed myelination and development | 4 | 4 | 1 |
| autosomal recessive osteopetrosis 5 | 1 | 1 | 1 |
| autosomal recessive osteopetrosis 8 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CLCN7 | 5 / 7 | autosomal dominant osteopetrosis 2, autosomal recessive osteopetrosis 4, hypopigmentation, organomegaly, and delayed myelination and development, Osteopetrosis and 1 more |
| LRP5 | 2 / 7 | Osteopetrosis, Osteosclerosis |
| OSTM1 | 2 / 7 | autosomal recessive osteopetrosis 5, Osteopetrosis |
| SNX10 | 2 / 7 | autosomal recessive osteopetrosis 8, Osteopetrosis |
| TCIRG1 | 2 / 7 | Osteopetrosis, Osteosclerosis |
| TNFRSF11A | 2 / 7 | Osteopetrosis, Osteosclerosis |
| TNFSF11 | 2 / 7 | Osteopetrosis, Osteosclerosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Collecting duct acid secretion | KEGG | 3 / 28 | 64.3× | 1.26e-5 | 4.07e-4 ✓ sig. |
| Stimuli-sensing channels | Reactome | 3 / 79 | 22.8× | 2.88e-4 | 5.20e-3 ✓ sig. |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | Reactome | 2 / 18 | 66.7× | 3.97e-4 | 6.66e-3 ✓ sig. |
| Rheumatoid arthritis | KEGG | 3 / 95 | 19.0× | 4.96e-4 | 7.92e-3 ✓ sig. |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | Reactome | 2 / 30 | 40.0× | 1.11e-3 | 1.47e-2 ✓ sig. |
| Breast cancer | KEGG | 3 / 148 | 12.2× | 1.79e-3 | 2.11e-2 ✓ sig. |
| Intracellular metabolism of fatty acids regulates insulin secretion | Reactome | 1 / 3 | 200× | 4.99e-3 | 4.37e-2 ✓ sig. |
| TNFR2 non-canonical NF-kB pathway | Reactome | 2 / 69 | 17.4× | 5.78e-3 | 4.83e-2 ✓ sig. |
| Prolactin signaling pathway | KEGG | 2 / 71 | 16.9× | 6.11e-3 | 5.00e-2 ✓ sig. |
| Toll Like Receptor TLR6:TLR2 Cascade | Reactome | 1 / 4 | 150× | 6.65e-3 | 5.28e-2 |
| Gastric acid secretion | KEGG | 2 / 76 | 15.8× | 6.97e-3 | 5.45e-2 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | Reactome | 1 / 5 | 120× | 8.30e-3 | 6.10e-2 |
| Scavenging by Class B Receptors | Reactome | 1 / 5 | 120× | 8.30e-3 | 6.10e-2 |
| Bile secretion | KEGG | 2 / 90 | 13.3× | 9.67e-3 | 6.73e-2 |
| Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling | Reactome | 1 / 6 | 100× | 9.95e-3 | 6.82e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| osteoclast differentiation | GO:0030316 | 7 / 49 | 133× | 4.12e-14 | 2.42e-11 ✓ sig. |
| positive regulation of bone resorption | GO:0045780 | 4 / 15 | 249× | 1.29e-9 | 2.82e-7 ✓ sig. |
| tooth eruption | GO:0044691 | 3 / 5 | 561× | 1.05e-8 | 1.78e-6 ✓ sig. |
| bone resorption | GO:0045453 | 4 / 26 | 144× | 1.40e-8 | 2.30e-6 ✓ sig. |
| transepithelial chloride transport | GO:0030321 | 3 / 9 | 311× | 8.77e-8 | 1.08e-5 ✓ sig. |
| regulation of osteoblast differentiation | GO:0045667 | 3 / 17 | 165× | 7.06e-7 | 6.27e-5 ✓ sig. |
| bone remodeling | GO:0046849 | 3 / 18 | 156× | 8.47e-7 | 7.24e-5 ✓ sig. |
| positive regulation of fever generation by positive regulation of prostaglandin secretion | GO:0071812 | 2 / 2 | 934× | 1.09e-6 | 8.87e-5 ✓ sig. |
| osteoclast proliferation | GO:0002158 | 2 / 5 | 374× | 1.09e-5 | 5.55e-4 ✓ sig. |
| establishment of blood-retinal barrier | GO:1990963 | 2 / 6 | 311× | 1.63e-5 | 7.66e-4 ✓ sig. |
| positive regulation of homotypic cell-cell adhesion | GO:0034112 | 2 / 7 | 267× | 2.28e-5 | 9.93e-4 ✓ sig. |
| establishment of blood-brain barrier | GO:0060856 | 2 / 11 | 170× | 5.95e-5 | 2.04e-3 ✓ sig. |
| regulation of osteoclast differentiation | GO:0045670 | 2 / 14 | 133× | 9.83e-5 | 2.98e-3 ✓ sig. |
| mammary gland alveolus development | GO:0060749 | 2 / 17 | 110× | 1.47e-4 | 4.02e-3 ✓ sig. |
| gastrulation with mouth forming second | GO:0001702 | 2 / 17 | 110× | 1.47e-4 | 4.02e-3 ✓ sig. |